Evidence of in vivo peroxynitrite formation in patients with colorectal carcinoma, higher plasma nitrate/nitrite levels, and lower protection against oxygen free radicals

Journal of Clinical Gastroenterology

Volumn 30, Issue 1, 2000, Pages 47-51

  Szaleczky, Erika ^a   Prónai, László ^a,c   Nakazawa, Hiroe ^b   Tulassay, Zsolt ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE   (Hungary)

Author keywords

Colorectal cancer; Free radicals; Inflammatory bowel disease; Nitric oxide; Nitrotyrosine; Peroxynitrite; Superoxide scavenging activity

Indexed keywords

3 NITROTYROSINE; NITRATE; NITRITE; OXYGEN RADICAL; PEROXYNITRITE; SCAVENGER; SUPEROXIDE; THIOL GROUP;

ADENOCARCINOMA; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CANCER STAGING; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENTERITIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRITES; OXIDANTS; REACTIVE OXYGEN SPECIES;

EID: 0342545882     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200001000-00008     Document Type: Article

References (23)

1. Prónai L, Szaleczky E, Fehér J. Ni trogen-oxide. Basic research an clinical application. Orv Hetil 1996;137:1699-704.
2. Prior WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995;268:L699-722.
3. Rhodes PM, Leone Am, Francis PL, et al. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasting humans. Biochem Biophys Res Commun 1995;209:590-6.
4. Prónai L, Arimori S, Fehér J. Superoxide scavenging activity of plasma in various immunological disorders-helpful parameter to detect the actual activity of ongoing inflammation. In: Fehér J, Blázovics A, Matkovics B, Mézes M, eds. Role of free radicals in biological systems. Budapest: Akadémia Könyvkiadó, 1993:21-7.
5. Kaur H, Halliwell B. Evidence for nitric-oxide mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid arthritis patients. FEBS Lett 1994;350:9-12.
6. 15N] nitrate in biological fluids. Anal Biochem 1982;126:131-8.
7. Prónai L, Ichikawa Y, Ichimori K, et al. Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity. Clin Exp Rheumatol 1991;9:149-55.
8. Sedlak J, Lindsay R. Estimation of total, protein bound and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:195-205.
9. Edwards P, Cendan JC, Topping DB, et al. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 1996;63:49-52.
10. Thomsen LL, Miles DW, Happerfield L, et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72(1):41-4.
11. Jenkins DC, Charles IG, Baylis SA, et al. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994;70:847-9.
12. Duenas-Gonzalez A, Isales CM, del Mar-Abad-Hernandez M. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod Pathol 1997;10(7):645-9.
13. Xie K, Dong Z, Fidler IJ. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J Leukoc Biol 1996;59:798-803.
14. Klotz T, Bloch W, Volberg C, et al. Selective expression of inducible in human prostate carcinoma. Cancer 1998;82(10):1897-903.
15. Liu CY, Wang CH, Chen TC, et al. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br J Cancer 1998;78(4):534-41.
16. Moriyama A. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Am J Gastroenterol 1997;92(9):1520-3.
17. Joossens JV, Hill MJ, Elliott P, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996;25:494-504.
18. La Vecchia C, D'Avanzo B, Airoldi L, et al. Nitrosamine intake and gastric cancer risk. Eur J Cancer Prev 1995;4:469-74.
19. Morales-Suarez-Varela MM, Llopis-Gonzales A, Tejerizo-Perez ML. Impact of nitrates in drinking water on cancer mortality in Valencia, Spain. Eur J Epidemiol 1995;11:15-21.
20. Pobel D, Riboli E, Cornee J, Hemon B, Guyader M. Nitrosamine, nitrate and nitrite in relation to gastric cancer: a case-control study in Marseille, France. Eur J Epidemiol 1995;11:67-73.
21. Bingham SA, Pignatelli B, Pollock JR, et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 1996;17:515-23.
22. Moochhala S, Chhatwal VJ, Chan ST, et al. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996;17:1171-4.
23. Fisher ER, Sass R, Palkar A, et al. Dakes' classification revisited. Findings from the national surgical adjurant breast and bowel projects (protocol R-01). Cancer 1989;64:2354-61.